87 related articles for article (PubMed ID: 7533180)
1. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
[TBL] [Abstract][Full Text] [Related]
2. CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6.
Hicks C; Keoshkerian E; Gaudry L; Lindeman R
Cancer Immunol Immunother; 2001 Jun; 50(4):173-80. PubMed ID: 11459169
[TBL] [Abstract][Full Text] [Related]
3. High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress.
Byrne SN; Halliday GM
Cancer Immunol Immunother; 2003 Jun; 52(6):396-402. PubMed ID: 12739069
[TBL] [Abstract][Full Text] [Related]
4. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.
Newton S; Ding Y; Chung CS; Chen Y; Lomas-Neira JL; Ayala A
Surg Infect (Larchmt); 2004; 5(4):375-83. PubMed ID: 15744129
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Ugurel S; Uhlig D; Pföhler C; Tilgen W; Schadendorf D; Reinhold U
Cancer Immunol Immunother; 2004 Jun; 53(6):551-9. PubMed ID: 14727087
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.
Foss DL; Zilliox MJ; Murtaugh MP
Infect Immun; 1999 Oct; 67(10):5275-81. PubMed ID: 10496906
[TBL] [Abstract][Full Text] [Related]
7. Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type.
Schoenbein C; Docke WD; Wolk K; Belbe G; Hoflich C; Jung M; Grutz G; Sterry W; Volk HD; Asadullah K; Sabat R
Clin Exp Immunol; 2008 Feb; 151(2):306-16. PubMed ID: 18062799
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression.
McCarthy DO; Glowacki N; Schell K; Emler CA; Albertini MR
Cancer Immunol Immunother; 2000 May; 49(2):85-93. PubMed ID: 10823418
[TBL] [Abstract][Full Text] [Related]
9. Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors.
Ikeda H; Nagasaki J; Shimizu D; Katsuya Y; Horinouchi H; Hosomi Y; Tanji E; Iwata T; Itami M; Kawazu M; Ohe Y; Suzuki T; Togashi Y
JTO Clin Res Rep; 2023 Oct; 4(10):100573. PubMed ID: 37799325
[TBL] [Abstract][Full Text] [Related]
10. Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer.
Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
Cancer Immunol Immunother; 2004 Nov; 53(11):1049-50. PubMed ID: 15449044
[No Abstract] [Full Text] [Related]
11. Optimizing the generation of mature bone marrow-derived dendritic cells in vitro: a factorial study design.
Alotaibi N; Aldahlawi A; Zaher K; Basingab F; Alrahimi J
J Genet Eng Biotechnol; 2023 Nov; 21(1):144. PubMed ID: 38017248
[TBL] [Abstract][Full Text] [Related]
12. Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma.
Chun KH; Park YC; Hwang N; Yoon BK; Kim JW; Fang S
Sci Rep; 2023 Sep; 13(1):15023. PubMed ID: 37700026
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Akbarzadeh A; Alirezaei P; Doosti-Irani A; Mehrpooya M; Nouri F
Dermatol Res Pract; 2022; 2022():4549134. PubMed ID: 36249714
[TBL] [Abstract][Full Text] [Related]
14. Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease.
Bhat DK; Olkhanud PB; Gangaplara A; Seifuddin F; Pirooznia M; Biancotto A; Fantoni G; Pittman C; Francis B; Dagur PK; Saxena A; McCoy JP; Pfeiffer RM; Fitzhugh CD
Front Immunol; 2021; 12():757279. PubMed ID: 34917079
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ: A cytokine at the right time, is in the right place.
Burke JD; Young HA
Semin Immunol; 2019 Jun; 43():101280. PubMed ID: 31221552
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Analgesic and Anti-Inflammatory Activities of Water Extract of
Sun K; Song X; Jia R; Yin Z; Zou Y; Li L; Yin L; He C; Liang X; Yue G; Cui Q; Yang Y
Evid Based Complement Alternat Med; 2018; 2018():6784032. PubMed ID: 29670660
[TBL] [Abstract][Full Text] [Related]
17. Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.
Tsai YC; Tsai TF
Ther Adv Musculoskelet Dis; 2017 Nov; 9(11):277-294. PubMed ID: 29344110
[TBL] [Abstract][Full Text] [Related]
18. Human γδ T cells augment antigen presentation in
Zhu Y; Wang H; Xu Y; Hu Y; Chen H; Cui L; Zhang J; He W
Mol Med; 2016 Dec; 22():737-746. PubMed ID: 27652377
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells.
Takenaka MC; Quintana FJ
Semin Immunopathol; 2017 Feb; 39(2):113-120. PubMed ID: 27646959
[TBL] [Abstract][Full Text] [Related]
20. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.
Sim JH; Kim HR; Chang SH; Kim IJ; Lipsky PE; Lee J
Arthritis Res Ther; 2015 Jul; 17(1):190. PubMed ID: 26209442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
